cbdMD (YCBD) Total Non-Current Liabilities (2016 - 2025)

cbdMD (YCBD) reported Total Non-Current Liabilities of $201235.0 for Q2 2025, down 93.2% on a YoY basis from $3.0 million in Q2 2024, and down 49.71% sequentially from $400144.0 in Q1 2025.

cbdMD (YCBD) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of Total Non-Current Liabilities data on file, last reported at $201235.0 in Q2 2025.

  • For the quarter ending Q2 2025, Total Non-Current Liabilities fell 93.2% year-over-year to $201235.0; the trailing twelve-month figure through Jun 2025 stood at $201235.0 (down 93.2% YoY), and the FY2023 full-year result was $2.5 million, down 38.91% from the prior year.
  • Total Non-Current Liabilities eased to $201235.0 in Q2 2025, from $400144.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $28.3 million in Q1 2021 to a low of $201235.0 in Q2 2025.
  • A 5-year average of $6.5 million and a median of $3.6 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 93.46% in 2021 and slumped 93.2% in 2025, its largest moves.
  • Tracing YCBD's Total Non-Current Liabilities over 5 years: stood at $8.2 million in 2021, then slumped by 56.11% to $3.6 million in 2022, then slumped by 41.77% to $2.1 million in 2023, then slumped by 71.65% to $591583.0 in 2024, then sank by 65.98% to $201235.0 in 2025.
  • Business Quant data shows YCBD's Total Non-Current Liabilities at $201235.0 in Q2 2025, $400144.0 in Q1 2025, and $591583.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 201,235.00
Mar 31, 2025 400,144.00
Dec 31, 2024 591,583.00
Jun 30, 2024 2.96 Mn
Mar 31, 2024 4.53 Mn
Dec 31, 2023 2.09 Mn
Sep 30, 2023 2.49 Mn
Jun 30, 2023 2.85 Mn
Mar 31, 2023 3.22 Mn
Dec 31, 2022 3.58 Mn
Sep 30, 2022 4.08 Mn
Jun 30, 2022 4.81 Mn
Mar 31, 2022 7.18 Mn
Dec 31, 2021 8.17 Mn
Sep 30, 2021 14.82 Mn
Jun 30, 2021 19.49 Mn
Mar 31, 2021 28.31 Mn
Dec 31, 2020 31.62 Mn
Sep 30, 2020 23.97 Mn
Jun 30, 2020 23.34 Mn